There’s no evidence showing that remdesivir, the first treatment approved for COVID-19, killed patients taking the drug. The antiviral drug is still approved by the U.S. Food and Drug Administration ...

A recent review of more than 100 studies revealed that stroke patients delayed seeking emergency care during COVID-19, effectively becoming sicker and facing worse outcomes.

We conducted a phase 2–3 double-blind trial to assess the efficacy and safety of nirmatrelvir–ritonavir in asymptomatic, rapid antigen test–negative adults who had been exposed to a household contact ...

COVID-19 may increase the risk of Alzheimer’s disease, especially for those who experience a severe infection. COVID-19 causes inflammation and other physiological changes in the brain that are ...

Despite frequent mentions of scientific evidence, U.S. media largely ignored uncertainties and relied on non-experts, fueling public confusion during the early COVID-19 crisis. In a recent study ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. A summer COVID-19 surge is underway, raising concerns over the CDC's "bluewashing" of its ...

When the World Health Organization declared Covid-19 a pandemic in March 2020, South Africa responded with one of the world’s longest national lockdowns, stretching from March 2020 to June 2022. H ...

Add Yahoo as a preferred source to see more of our stories on Google. A discredited study that set off a flurry of interest in using an antimalarial drug to treat COVID-19 has now been formally ...